Top Gainers with High Volume Are Good Takeover Indicators (OMPI, GEVO, CIE, WSM)
New York, NY -- (SBWIRE) -- 03/20/2013 -- Obagi Medical Products, Inc. (NASDAQ:OMPI) a specialty pharmaceutical company that develops, markets, and sells topical aesthetic and therapeutic prescription skin care systems is currently up (+27.94%) on 8,809,184 shares traded after Valeant Pharmaceuticals International Inc said it would buy Obagi Medical Products Inc for about $344 million to boost its dermatology business. Obagi Medical Products, Inc. (NASDAQ: OMPI) are currently up (+84.21%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here